Digital Health Product Regulation

Summary

This practice note provides an overview of U.S. Food and Drug Administration (FDA) regulation of digital health products that utilize artificial intelligence and software products considered to be clinical decision support (CDS) software. In particular, this practice note discusses FDA's regulatory framework for artificial intelligence/machine learning (AI/ML) devices and FDA's Final Guidance on clinical decision support (CDS) software.